When was Saga Diagnostics founded?

Saga Diagnostics was founded in 2016 and raised its 1st funding round within a year of its incorporation.

Where is Saga Diagnostics located?

Saga Diagnostics is headquartered in Morrisville, United States.

How many employees does Saga Diagnostics have?

As of Aug 31, 2026, the latest employee count at Saga Diagnostics is 85.

Is Saga Diagnostics a funded company?

Saga Diagnostics is a funded company, having raised a total of $17.9M across 7 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Apr 04, 2016.

When was the latest funding round of Saga Diagnostics?

Saga Diagnostics' latest funding was a $***** Series A round on Jun 29, 2021, with participation from 2 investors. Its primary sector is Oncology. In United States, the Oncology sector has seen $3.95B in funding in 2026 to date.

What is the annual revenue of Saga Diagnostics?

Annual revenue of Saga Diagnostics is between $1M and $10M as on Dec 31, 2022

Where does Saga Diagnostics rank among its competitors?

Saga Diagnostics ranks 11th amongst 525 active competitors, of which 155 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was GRAIL, which secured $110M in Jun, 2026.

Who are the top competitors of Saga Diagnostics?

Saga Diagnostics' top competitors include Guardant Health, Natera and Foundation Medicine. Among them, GRAIL secured the most recent funding round in June, 2026.

Saga Diagnostics - 2026 Company Profile, Funding, Competitors & Financials

Company Details

Provider of tests for detection and analysis of circulating tumor DNA. It uses next-generation sequencing and proprietary algorithms to detect the presence of cell-free tumor DNA in the blood. The products include SAGAsafe, SAGAsign, and SAGAseq to detect mutations and to measure the therapeutic effect. In addition, the company also provides services for the analysis of gene and chromosomal mutations.

Website: sagadiagnostics.com
Social

Key Metrics

Founded Year

2016

Location

Morrisville, United States

Stage

Acquired

Total Funding

$17.9M in 7 rounds

Latest Funding Round

Series A, Jun 29, 2021, $*****

Investors

Hadean Ventures & 12 more

Ranked

11^th among 525 active competitors

Annual Revenue

$1M - $10M as on Dec 31, 2022

Employee Count

85 as on Aug 31, 2026

Similar Companies

Guardant Health & 646 more

Exit Details

Acquired by Foundation Medicine (Apr 16, 2026)

View Saga Diagnostics' full profile

Saga Diagnostics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Saga Diagnostics Ab CIN: 559050-3305 , Sweden, Active	Feb 04, 2016	$1M - $10M (As on Dec 31, 2022)	-	-

Saga Diagnostics got acquired by Foundation Medicine on Apr 16, 2026 at an acquisition amount of $*****.

Click here to take a look at Saga Diagnostics's acquisition in detail

Saga Diagnostics has raised a total funding of $17.9M over 7 rounds. Its first funding round was on Apr 04, 2016. Its latest funding round was a Series A round on Jun 29, 2021 for $*****. 2 investors participated in its latest round. Saga Diagnostics has 10 institutional investors and 3 angel investors.

Here is the list of recent funding rounds of Saga Diagnostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 29, 2021	3208661	Series A	8242366	6200106	5890681	9771375
Feb 01, 2021	3888811	Grant (prize money)	9633043	3171094	7436404	Europa
Jun 11, 2019	4278596	Series A	4418412	5227901	Hadean Ventures	Cancerstiftelsen & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Saga Diagnostics's funding rounds and investors

Saga Diagnostics' employee count trend

Saga Diagnostics has 85 employees as of Aug 26. Here is Saga Diagnostics's employee count trend over the years:

Employee count trend for Saga Diagnostics

Uncover Saga Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Saga Diagnostics include Guardant Health, Natera and Foundation Medicine. Here is the list of Top 10 competitors of Saga Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Guardant Health 2012, Redwood City (United States), Public	Developer of digital sequencing technology for cancer detection	$557M	SoftBank Vision Fund, Lightspeed Venture Partners ... & 25 others	79/100
2nd	Natera 2004, Redwood City (United States), Public	Developer of cell-free DNA testing for oncology, women’s health, and organ health	$152M	Harmony Partners, Bain Capital Life Sciences ... & 18 others	77/100
3rd	Foundation Medicine 2010, Cambridge (United States), Acquired	Provider of genomics-based diagnostics test for cancer	$96.5M	Redmile Group, Deerfield & 11 others	70/100
4th	Prenetics 2009, Hong Kong (China), Public	Online platform for genetic and diagnostic health testing that helps identify health risks	$67.6M	Apis Partners, Beyond Ventures & 22 others	69/100
5th	GRAIL 2016, Menlo Park (United States), Public	Developer of a screening platform for circulating tumor DNA to detect cancer	$2B	Arch Venture Partners, Hillhouse & 52 others	69/100
6th	BillionToOne 2015, San Francisco (United States), Public	Provider of cell-free cancer liquid biopsy test	$389M	Hummingbird Ventures, Adams Street Partners ... & 31 others	69/100
7th	Myriad Genetics 1991, United States, Public	Developer of molecular diagnostics and personalized medicine for cancer	-	Grayhawk Capital, TriplePoint Capital & 6 others	68/100
8th	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Coatue & 19 others	66/100
9th	Foresight Diagnostics 2020, Aurora (United States), Acquired	Developer of minimally-invasive liquid biopsy test for the detection of cancer	$104M	Foresite Capital, Bluebird Ventures & 6 others	66/100
10th	Scipher Medicine 2014, Waltham (United States), Series D	Provider of precision medicine based on liquid biopsy test	$233M	Northpond Ventures, Cowen & 14 others	65/100
11th	Saga Diagnostics 2016, Morrisville (United States), Acquired	Provider of tests for detection and analysis of circulating tumor DNA	$17.9M	Hadean Ventures, EIC Fund & 11 others	64/100